Varvara Polydoropoulou

Author

Frontier Science Foundation-Hellas

Also Known As

V Polydoropoulou, V. Polydoropoulou, Varvara Polydoropoulou, Zoi Tsourti

Publications

896

Citations

H-Index

Concepts

All Affiliations

Frontier Science Foundation-Hellas University Hospital of Zurich University Hospital of Lausanne Royal Marsden Hospital University of Chieti-Pescara

About

Varvara Polydoropoulou is an author at Frontier Science Foundation-Hellas specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	234
2	Health Sciences	2	2	138
3	Pathology	2	2	96
4	Pulmonary Disease	2	2	96
5	Cancer Therapeutics	1	1	54

Varvara Polydoropoulou

Publications

622

Citations

H-Index

Page 1

	Year	Citations
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni, Annals of Oncology	2020	265
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab Sherene Loi, Urania Dafni, Dimitris Karlis, JAMA Oncology	2016	93
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project Igor Letovanec, Stephen P. Finn, Panagiota Zygoura, Journal of Thoracic Oncology Advanced Lung DiseaseEuropean Nsclc PatientsMedicineAlk RearrangementBronchial Neoplasm	2017	84
A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial Sanjay Popat, Alessandra Curioni‐Fontecedro, Varvara Polydoropoulou, Annals of Oncology OncologyPhase Iii TrialClinical TrialsPleural DiseaseEtop 9-15	2019	54
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project Keith M. Kerr, Urania Dafni, Katja Schulze, Annals of Oncology Multiplex MutationMedicineGeneticsGenetic EpidemiologyPathology	2017	49
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project Keith M. Kerr, Erik Thunnissen, Urania Dafni, Lung Cancer Retrospective Cohort StudyAdvanced Lung DiseaseMedicinePathologyPd-l1 Prevalence	2019	47
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study Martin Filipits, Urania Dafni, Michael Gnant, Clinical Cancer Research	2018	30

Page 1